Drug Shortage Report for DANTRIUM INTRAVENOUS

Last updated on 2023-07-28 History
Report ID 194917
Drug Identification Number 01997572
Brand name DANTRIUM INTRAVENOUS
Common or Proper name DANTROLENE SODIUM
Company Name ENDO PAR INNOVATION COMPANY, LLC
Market Status MARKETED
Active Ingredient(s) DANTROLENE SODIUM
Strength(s) 20MG
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 6x 20mg
ATC code M03CA
ATC description MUSCLE RELAXANTS, DIRECTLY ACTING AGENTS
Reason for shortage Delay in shipping of the drug.
Anticipated start date
Actual start date 2023-06-12
Estimated end date 2023-07-21
Actual end date 2023-07-24
Shortage status Resolved
Updated date 2023-07-28
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 6 RAM RIDGE ROAD
CHESTNUT RIDGE, NEW YORK
UNITED STATES 10977
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v12 2023-07-28 French Compare
v11 2023-07-28 English Compare
v10 2023-07-13 French Compare
v9 2023-07-13 English Compare
v8 2023-07-07 French Compare
v7 2023-07-07 English Compare
v6 2023-06-29 French Compare
v5 2023-06-29 English Compare
v4 2023-06-22 French Compare
v3 2023-06-22 English Compare
v2 2023-06-14 French Compare
v1 2023-06-14 English Compare

Showing 1 to 12 of 12